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Abstract
Relative to European Americans, type 2 diabetes (T2D) is more prevalent in African Americans 
(AAs). Genetic variation may modulate transcript abundance in insulin-responsive tissues and 
contribute to risk; yet published studies identifying expression quantitative trait loci (eQTLs) in 
African ancestry populations are restricted to blood cells. This study aims to develop a map of 
genetically regulated transcripts expressed in tissues important for glucose homeostasis in AAs, 
critical for identifying the genetic etiology of T2D and related traits. Quantitative measures of 
adipose and muscle gene expression, and genotypic data were integrated in 260 non-diabetic AAs 
to identify expression regulatory variants. Their roles in genetic susceptibility to T2D, and related 
metabolic phenotypes were evaluated by mining GWAS datasets. eQTL analysis identified 1,971 
and 2,078 cis-eGenes in adipose and muscle, respectively. Cis-eQTLs for 885 transcripts including 
top cis-eGenes CHURC1, USMG5, and ERAP2, were identified in both tissues. 62.1% of top cis-
eSNPs were within ±50kb of transcription start sites and cis-eGenes were enriched for 
mitochondrial transcripts. Mining GWAS databases revealed association of cis-eSNPs for more 
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than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes, (e.g. 
INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4). Integration of GWAS 
meta-analysis data from AA cohorts revealed the most significant association for cis-eSNPs of 
ATP5SL and MCCC1 genes, with T2D and BMI, respectively. This study developed the first 
comprehensive map of adipose and muscle tissue eQTLs in AAs (publically accessible at https://
mdsetaa.phs.wakehealth.edu) and identified genetically-regulated transcripts for delineating 
genetic causes of T2D, and related metabolic phenotypes.
Keywords
Expression Quantitative Trait (eQTL); Genotype; Transcript; Single nucleotide polymorphism 
(SNP); Adipose; Muscle; African American; Genomics; Diabetes; Obesity
 INTRODUCTION
The importance of genetic factors in modulating the susceptibility to type 2 diabetes (T2D) 
is well established (Groop and Pociot, 2014). Relative to European Americans, T2D is twice 
as prevalent in African Americans (Cowie et al., 2010) and associated risk factors such as 
insulin resistance and obesity are more prevalent (Cowie et al., 1993). Whether genetic 
variation modulates molecular processes and contributes to the enhanced susceptibility to 
T2D in African Americans is unknown. Large-scale linkage, candidate-gene, and genome-
wide association studies (GWAS), primarily in European and Asian populations, have 
identified approximately 88 loci associated with T2D and 83 loci associated with glucose 
homoeostasis-related phenotypes (Mohlke and Boehnke, 2015). T2D-associated loci 
identified in GWAS reveal relatively weak effects, together explaining only a small fraction 
of the heritability in African Americans (Mahajan et al., 2014;Ng et al., 2014). Moreover, 
most associated variants are located in noncoding genomic regions. Thus, determining how 
these loci modulate systemic glucose homeostasis at the molecular level remains unclear. 
Approaches investigating molecular endophenotypes more proximal to gene products may 
assist in identifying the molecular basis of genetic susceptibility to T2D in African 
Americans.
Genetic variation can impact transcript abundance. We and others reported that T2D- and 
related trait-associated variants are enriched for expression-regulatory single nucleotide 
polymorphisms (eSNPs) in tissues important for glucose homeostasis (Das and Sharma, 
2014;GTEx consortium, 2015;Nicolae et al., 2010). Identifying genetic variants associated 
with transcript expression in metabolically relevant tissues may identify functionally 
meaningful sets of SNPs involved in T2D, obesity, and related metabolic phenotypes. 
However, studies on the genetics of gene expression in populations of African ancestry are 
predominantly limited to lymphocytes/lymphoblastoid cell lines (Storey et al., 2007;Stranger 
et al., 2012;Zhang et al., 2008). The goal of this study was to identify genetic regulatory 
variants modulating expression of adipose and muscle transcripts in African Americans at 
risk for T2D and evaluate their role in susceptibility to T2D, obesity, and related metabolic 
disorders. A systematic analysis was performed on the genome-wide transcript expression 
profiles of insulin responsive tissues (subcutaneous adipose and skeletal muscle) and 
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genome-wide SNP genotypes in a metabolically characterized cohort of 260 non-diabetic 
African Americans from North Carolina. To our knowledge, this is the largest existing 
cohort of non-diabetic African Americans characterized for gluco-metabolic phenotypes 
with available biological samples (DNA and tissue) for conducting an integrative multi-
omics approach. These data were used to test two hypotheses: 1) expression levels of a 
subset of transcripts would associate with genotype and manifest as expression quantitative 
trait loci (eQTL) in both adipose and muscle, while a subset of transcripts would be 
modulated by tissue-specific eQTLs; and 2) a subset of the expression regulatory SNPs 
(eSNPs) would associate with glucose homeostasis related phenotypes, obesity and/or T2D 
in large GWAS, identifying putative causal SNPs in African Americans.
 MATERIALS AND METHODS
 Human subjects
Participants were healthy, self-reported African Americans residing in North Carolina aged 
18–60 years with a body mass index (BMI) between 18 and 42 kg/m2. A total of 260 
unrelated non-diabetic individuals completed all study visits and are referred to as the 
“African American Genetics of Metabolism and Expression” (AAGMEx) cohort; 
subcutaneous adipose tissue (from the abdomen near the umbilicus) and skeletal muscle 
(from the vastus lateralis) biopsies were collected from 256 individuals. Studies were 
performed at the Wake Forest School of Medicine (WFSM) Clinical Research Unit. This 
study was approved by the WFSM Institutional Review Board and all participants provided 
written informed consent.
A standard 75-g oral glucose tolerance test (OGTT) was used to exclude individuals with 
diabetes and results were analyzed by homeostatic model assessment (HOMA; http://
mmatsuda.diabetes-smc.jp/MIndex.html) to evaluate insulin sensitivity (Matsuda Index) and 
insulin resistance (HOMA-IR) (Matsuda and DeFronzo, 1999; Matthews et al., 1985). High 
quality insulin modified (0.03 U/kg) frequently sampled intravenous glucose tolerance test 
(FSIGT) data were available in 235 participants. The MINMOD Millennium program was 
used to analyze FSIGT data to determine insulin sensitivity (SI) and acute insulin response 
(AIRG) (Bergman et al., 2014). Clinical, anthropometric, and physiological characteristics of 
the AAGMEx cohort have been described (Sharma et al., 2016).
 Gene expression analysis and genotyping
Genome-wide expression data were generated using HumanHT-12 v4 Expression BeadChip 
(Illumina, San Diego, CA) whole genome gene expression arrays for quantitative analyses of 
transcript expression in adipose and muscle samples. Infinium HumanOmni5Exome-4 v1.1 
DNA Analysis BeadChips (Illumina) were used to genotype DNA samples based on the 
manufacturer’s recommendations. Additional technical details of standard gene expression 
analyses and genotyping methods are described in Supplementary methods.
 Quality control
Detailed data quality control methods are presented in Supplementary methods. In brief, 
measures of glucose homeostasis and obesity were examined for outliers in a univariate 
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fashion and as correlated pairs. Genome-wide gene expression data (probe level) for both the 
adipose and muscle samples were extracted separately using Illumina GenomeStudio 
V2011.1. Expression level was log2 transformed, robust multi-array average normalized 
(RMA, includes quantile normalization) (Irizarry et al., 2003) and batch-corrected using 
ComBat (Johnson et al., 2007). The HumanHT-12 v4 Expression BeadChip includes 47,231 
probes annotated to transcripts. Significant expression (p<0.05) of 16,010 and 13,118 
transcript probes was observed in adipose and muscle RNA, respectively, in 90% of 
participants. Data from these probes were primarily used for analysis. Probes were further 
filtered out based on bioinformatic criteria described in the supplementary methods. 
Genotype data were examined to verify sample and SNP quality. Genotype assays of 
4,210,443 SNPs passed technical quality filters. The genotype of 2,296,925 autosomal SNP 
assays (representing 2,210,735 unique high-quality genotyped SNPs with MAF>0.01 and 
HWE-p value >1×10−6) was used in eQTL analysis.
 Statistical and Bioinformatic analyses
To identify expression quantitative trait loci (eQTLs), linear regression was computed with 
the log2 transformed expression values as the outcome and an additive genetic model for the 
SNP as implemented in the R-package MatrixEQTL (Shabalin, 2012); age, gender, and 
African ancestry proportion were covariates. Analyses scanned for both cis and trans eQTLs, 
but partitioned the overall type 1 error rate of α=0.05 into α=0.04 for cis and α=0.01 for 
trans. However, we considered as significant any cis- and trans-eSNPs with a false discovery 
rate (FDR)-corrected p-value (Q-value) <0.01 (or 1.0%). Detailed statistical and 
bioinformatic data analysis methods are presented in Supplementary methods. Sample sizes 
in each analysis (Supplementary Table 1) varied based on available data after quality control.
 Replication of eQTL data
Adipose cis-eQTL data from the Multiple Tissue Human Expression Resource (MuTHER) 
project (Grundberg et al., 2012) and muscle cis-eQTL data reported by Keildson et al. 
(Keildson et al., 2014) were mined to replicate cis-eGenes identified in the AAGMEx cohort 
(Supplementary Methods). Additionally, replication of adipose and muscle cis-eGenes was 
tested in publically available tissue eQTL data from GTEx project (GTEx_Analysis_v6 
updated) and lymphoblastoid cell line (LCL) eQTL data from both the Geuvadis RNA 
sequencing project and the SeeQTL data depository.
 Integration of GWAS data
Cis-eSNPs identified in adipose and muscle of African Americans represented a prioritized 
set of SNPs providing statistical evidence for genotype-dependent variation in transcript 
abundance. The NHGRI Catalog of Published GWAS (Hindorff et al., 2009) and meta-
analysis data from the Meta-Analyses of Glucose and Insulin-related traits Consortium 
(MAGIC) (Scott et al., 2012) were mined to identify the role of putatively functional SNPs 
in T2D susceptibility and gluco-metabolic phenotypes. We also searched for associations of 
eSNPs with T2D and BMI in the Meta-analysis of Type 2 Diabetes in African Americans 
(MEDIA) Consortium (Ng et al., 2014) and African Ancestry Anthropometry Genetic 
Consortium (AAAGC) (Monda et al., 2013) GWAS (Supplementary Methods).
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 RESULTS
 eQTLs identified in adipose and muscle
We identified 1971 and 2078 transcripts with at least one significant cis-eQTL (top eSNP 
within ±500kb around the expressed transcript at FDR <0.01) in adipose and muscle, 
respectively (Figure 1A, 1B, Supplementary Tables 2 and 3). These transcripts were 
considered cis-eGenes.
Overlap between cis-eGenes was identified in adipose and muscle. Cis-eQTLs for 885 
transcripts were identified in both insulin-responsive tissues (Figure 1B). Among these, 317 
were most strongly associated with the same cis-eSNPs in both tissues and showed the same 
direction of effect (Figure 1C and Supplementary Table 4). The most significant cis-eGenes 
(FDR <1×10−100) observed in both tissues included churchill domain containing 1 
(CHURC1), up-regulated during skeletal muscle growth-homolog 5 (USMG5), and 
endoplasmic reticulum aminopeptidase 2 (ERAP2) (Table 1).
SNP–transcript expression-level associations for variants located on other chromosomes or 
outside the defined cis boundary (±500kb around the transcript) were examined to identify 
trans-regulatory variants. Associations were identified (FDR<0.01) for expression of 603 
and 943 transcripts with a genotype of at least one trans-eSNP in adipose and muscle, 
respectively (data not shown). Considering the large number of tests performed to identify 
trans-eQTLs, we conservatively considered a transcript associated with >1 trans-eSNP as 
statistically significant. Using this conservative criterion, 322 and 591 trans-eGenes were 
identified in adipose and muscle, respectively. Overlap of these trans-eGenes with cis-
eGenes is shown in Figure 1B. Summary statistics of all cis- and trans-eSNPs is publically 
accessible through a searchable database at https://mdsetaa.phs.wakehealth.edu.
 Genomic distribution of cis-eSNPs
The distribution of the top cis-eSNPs for each transcript was assessed in relation to gene 
proximity and plotted against the distribution of distances between cis-eSNPs with the 
lowest p-values and transcription start site (TSS). As reported (Stranger et al., 2005;Stranger 
et al., 2007;Veyrieras et al., 2008), the majority of top cis-eSNPs in adipose (62.6%) and 
muscle (61.7%) were located within ±50kb of the TSS (Figure 2A and 2B). For adipose, 
80% and 95% of the top cis-eSNPs were within 118.6 kb and 374.4 kb, respectively, of the 
TSS. For muscle, these distances were 122.8 kb and 371.4 kb, respectively. Cis-eSNPs with 
larger effect sizes were also overrepresented close to TSS (Figure 2C and 2D). Greater than 
80% (80.8% in adipose; 84% in muscle) of the highly significant cis-eSNPs (P-value 
<1×10−10) were located within ±100 kb of the TSS. To assess potential functional 
significance, we annotated the genomic locations (based on the Sequence Ontology 
definitions) of the top cis-eSNPs of associated transcripts (FDR<0.01). Interestingly, 79.6% 
of the top cis-eSNPs were located within or near gene regions (±5 kb), and only 20.4% were 
intergenic. Most of the top cis-eSNPs were intronic (43.1%) or in the 3’ or 5’ untranslated 
regions (UTR, 16.3%, Figure 3). Utilizing the TRANSFAC Database, SNPnexus (Dayem 
Ullah et al., 2012) annotation predicted the disruption of transcription factor binding sites by 
80 and 77 top cis-eSNPs in adipose and muscle, respectively.
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 In silico analyses indicate functional significance of cis-eGenes
Gene-annotation enrichment analysis with DAVID (Huang et al., 2009) indicated an 
enrichment of mitochondrial genes (GO:0005739) among cis-eGenes in both adipose 
(p=4.67×10−11, 141 transcripts) and muscle (p=4.84×10−30, 235 transcripts). Although not 
strongly enriched, cis-eGenes in both adipose (34 genes, p=0.03, FDR=26.5%) and muscle 
(47 genes, p=0.0079, FDR= 7.8%) included genes involved in diabetes based on Reactome 
pathway annotation (Reactome pathway, REACT_15380: Diabetes pathways). IPA predicted 
HNF4A (a transcription factor) as the most common upstream regulatory factor for adipose 
(p-value of overlap=2.23×10−15, 254 transcripts) and muscle (p=3.82×10−22 , 288 genes) 
cis-eGenes identified. Expression of a subset of cis-eGenes (362 in adipose; 42 in muscle) 
was associated with SI in this non-diabetic African American cohort (Sharma et al., 2016).
 Replication of cis-eQTLs using publically available data
Published studies for eQTLs in insulin-responsive tissues in African Americans are not 
available. Replication of eQTLs was assessed by mining published adipose and muscle 
eQTLs in Caucasians (populations of European ancestry). Adipose eQTL data from 
MuTHER (Grundberg et al., 2012) were assessed for replication of 190 top cis-eGenes 
identified in AAGMEx (included probes for 100 top cis-eGenes and 100 top SI-associated 
cis-eGenes). Information for 155 of the 190 selected probes was available in MuTHER. 
Comparison of data sets showed an association of 114 cis-eGenes (probes) with the same 
cis-eSNPs in both studies (Supplementary Table 5), supporting replication of 73.5% of top 
adipose cis-eQTLs in our AAGMEx cohort.
Muscle cis-eQTLs as reported by Keildson et al. (Keildson et al., 2014), were searched to 
assess replication of these cis-eGenes (n=287) in the AAGMEx cohort, considering all 
probes representing significant (up to FDR <0.04) cis-eGenes. Comparison of the two 
muscle-eQTL data sets showed an association of 144 cis-eGenes (represented by 191 
probes, Supplementary Table 6). Despite the small sample and different design of the 
previous study by Keildson et al., 50.2% of their muscle-eGenes were replicated in our 
AAGMEx African American cohort. Despite different methods of transcript quantification 
(RNA-seq) and sample characteristics (N=298 and 361 cadaver donors for subcutaneous 
adipose and skeletal muscle, respectively), results from GTEx (GTEx_Analysis_v6 updated: 
2015-06-18, dbGaP Accession phs000424.v6.p1) (GTEx consortium, 2015) supported 
replication of 965 adipose cis-eGenes and 1016 muscle cis-eGenes from AAGMEx (data not 
shown).
To determine the replication of adipose and muscle tissue cis-eGenes in surrogate tissues, 
publically available eQTL data for transformed lymphoblastoid cell lines (LCL) were 
searched. The LCL-eQTL data from a small African ancestry cohort (Geuvadis RNA 
sequencing project of 1000 Genomes YRI samples, N= 89; http://www.geuvadis.org/web/
geuvadis/RNAseq-project), replicated 96 and 95 adipose and muscle tissue-identified cis-
eGenes, respectively. However, replication was much higher when larger LCL-eQTL 
datasets, e.g. HapMap3 consensus cis-eQTL (SeeQTL; http://www.bios.unc.edu/research/
genomic_software/seeQTL) were searched for comparison. Considering cis-eGenes at 
q<0.01 from SeeQTL data, ~24% of AAGMEx adipose and muscle cis-eGenes (448 in 
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adipose; 443 in muscle) were replicated in LCLs. Thus, expression of a subset of transcripts 
is genetically regulated across tissues, and the eQTL data from LCLs may be used as a 
proxy for identifying a small subset of adipose and muscle tissue cis-eGenes.
 Association of cis-eSNPs with T2D, obesity and related metabolic phenotypes
The NHGRI Catalog of Published GWAS (from UCSC table browser) was mined (Hindorff 
et al., 2009) for association of all significant cis-eSNPs (FDR<0.01) for adipose and muscle 
transcripts to identify potential roles in T2D susceptibility and related phenotypes. This 
catalog only includes phenotype-associated index SNPs (p-values <1.0×10−5), mostly from 
people not of recent African descent. Association of cis-eSNPs was detected for >50 genes 
with gluco-metabolic phenotypes including T2D (e.g. PIK3C2A, RBMS1, UFSP1, ACHE), 
fasting plasma glucose (e.g. NOSTRIN, RREB1), hemoglobin A1c (e.g. FN3KRP), and 
BMI and obesity-related traits (e.g. POMC, MARCH6, NINJ1, RBP1, HMBOX1, 
CHURC1, CPEB4; Supplementary Table 7).
GWAS data from Caucasians in the MAGIC cohort (Scott et al., 2012) were assessed for 
glucose homeostasis phenotypes; Supplementary Table 8 lists cis-eSNPs for 54 adipose and 
63 muscle genes with evidence for association (p<0.01) with glucose homeostasis 
phenotypes. An eSNP (both adipose and muscle) for inositol polyphosphate-5-phosphatase 
(INPP5E) was strongly associated with fasting glucose (rs1128905, p=5.81×10−9), and an 
eSNP for ERAP2 was strongly associated with 2h-glucose (rs1019503, p=8.97×10−9 ). 
Interestingly, rs560887, located in the intron of the glucose-6-phosphatase catalytic subunit 
2 gene (G6PC2) was strongly associated with fasting glucose (p=1.4×10−178) in Caucasians 
in the MAGIC cohort, as was a cis-eSNP for NOSTRIN (nitric oxide synthase trafficker 
gene) in adipose of people in the AAGMEx cohort. Muscle eSNPs rs2068834 (sorting nexin 
17 gene, SNX17; p=9.78×10−20) and rs11715915 (macrophage stimulating 1 gene, MST1; 
p=4.90×10−8) associated with fasting glucose; eSNP rs6912327 (UHRF1 binding protein 1 
gene, UHRF1BP1) associated with BMI-adjusted fasting insulin (p=2.26×10−8).
A search for association of eSNPs (FDR <0.01) with T2D and BMI was performed in 
GWAS from MEDIA (Ng et al., 2014) and AAAGC (Monda et al., 2013). Cis-eSNPs for 72 
genes in adipose and 80 genes in muscle showed nominal evidence (p<0.01) of association 
with T2D in African Americans in the MEDIA cohort (Supplementary Table 9). Three cis-
eSNPs show stronger association (p<1.0×10−4) with T2D (Table-2A). A cis-eSNP for the 
transcript of ATP synthase subunit s-like protein (ATP5SL) gene was most significantly 
associated with T2D (rs7259208, p=1.20×10−5). Cis-eSNPs for 65 genes in adipose and 91 
genes in muscle showed nominal evidence of association (p<0.01) with BMI in African 
Americans in the AAAGC cohort (Supplementary Table 10). Four cis-eSNPs show stronger 
association (p<1.0×10−4) with BMI (Table-2B). Among the selected subset of cis-eSNPs, 
rs4074110 (methylcrotonoyl-CoA carboxylase 1, MCCC1) showed the most significant 
association with BMI (p=6.11×10−6) in meta-analyses from AAAGC data. Thus, cis-eSNPs 
may modulate the risk for T2D and obesity in African Americans.
Integration of AAGMEx eQTL results and GWAS of gluco-metabolic traits suggested 
putative target genes for GWAS-identified SNPs. A total of 216 and 249 target cis-eGenes in 
adipose and muscle, respectively, were identified. Among these target cis-eGenes, mRNA 
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expression of 55 genes in adipose, and 20 genes in muscle were significantly associated 
(p<0.001) with the glucose homeostasis traits (SI and AIRG derived from FSIGT; HOMA-IR 
and Matsuda index derived from OGTT), or obesity (BMI) phenotypes of AAGMEx 
participants (Supplementary Table 11).
 DISCUSSION
Despite successes in GWAS, the majority of loci accounting for T2D heritability remain 
unknown and the diversity of its pathophysiology, molecular mechanisms, and variants 
explaining enhanced susceptibility in African Americans are poorly understood. The present 
study combined gene expression in tissues important to insulin action, and genome-wide 
genotype data in African Americans to fill these gaps. Results provide a comprehensive map 
of genetically regulated transcripts in African Americans, which is critical for prioritizing 
GWAS-identified SNPs in replication studies and detecting functional roles of variants 
involved in T2D and related traits.
Integration of genome-wide expression and genotype data enabled mapping of loci involved 
in the regulation of gene expression. Association of SNPs with transcript levels of nearby 
(cis) or distal (trans) genes were identified. Compared to adipose, slightly more cis-eQTL-
transcripts (cis-eGenes) were found in muscle. Overlap of 885 cis-eQTL transcripts (~45% 
of cis-eGenes) was seen in both tissues indicating tissue- independent expression regulatory 
elements. Significant cis-eGenes observed in both tissues included USMG5 and ERAP2. 
The USMG5 gene, also known as the diabetes-associated protein in insulin-sensitive tissue 
gene (DAPIT), is differentially modulated in insulin-responsive tissues of streptozotocin-
treated diabetic rats (Kontro et al., 2012; Paivarinne and Kainulainen, 2001). ERAP2 is 
involved in maturation of many proteins in the endoplasmic reticulum (ER), and has been 
implicated in regulation of angiogenesis and blood pressure (Cifaldi et al., 2012). An eSNP 
for ERAP2 was strongly associated with 2h-glucose in the MAGIC cohort. Consistent with 
published eQTL studies (Stranger et al., 2005; Stranger et al., 2007; Veyrieras et al., 2008), 
top cis-eSNPs for 60% of transcripts in both tissues were within ±50 kb of the TSS. The 
genomic distribution of cis-eSNPs fits with existing knowledge on the genetic regulatory 
architecture of transcript expression. Further bioinformatic annotation of these loci indicated 
the disruption of transcription factor binding by eSNPs and provided evidence for regulatory 
motifs. Thus, the identified eQTLs support the concept that functional regulatory genomic 
regions exist in glucose homeostasis-regulating tissues. Many cis-eQTLs identified in this 
African American cohort were replicated in non-African cohorts. Thus, a subset of genetic 
regulatory mechanisms of transcript expression is common between African Americans and 
non-Africans. Further studies will be required to confirm, whether other subsets of genetic 
regulatory mechanisms of transcript expression predominately influence particular ancestral 
groups.
Enrichment (DAVID analysis) of mitochondrial genes was identified among adipose and 
muscle cis-eGenes, indicating a role for genetic factors in modulation of this pathway. IPA 
revealed enrichment of pathways involved in mitigating oxidative stress (including 
glutathione-mediated detoxification, p=8.32×10−3–3.72×10−5; NRF2-mediated oxidative 
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stress response, p=0.02-4.47×10−4) among cis-eGenes. These biological pathways may play 
key roles in modulating insulin sensitivity in African Americans.
Compared to cis-eQTLs, the effect sizes of trans-eQTLs are generally small, requiring larger 
sample sizes for robust detection of trans-eQTLs (Grundberg et al., 2012). A recent eQTL 
analysis in adipose tissue from Caucasian female twins (MuTHER Project, N=856) 
identified 3,529 cis-eQTLs (at FDR 1%) and 639 trans-eQTLs (at FDR 10%) (Grundberg et 
al., 2012). A stringent threshold (FDR<1%, with corresponding uncorrected p-values 
<2.6×10−9 in adipose tissue) was used to account for the large number of tests performed for 
trans-eQTL analysis in the AAGMEx cohort, and it identified 322 and 591 trans-eGenes in 
adipose and muscle, respectively. Thus, the number of trans-eGenes identified in AAGMEx 
is consistent with expectations and comparable to published studies on adipose and other 
tissues.
Mining of the NHGRI catalogue of GWAS (Hindorff et al., 2009) and MAGIC GWAS meta-
analysis (Scott et al., 2012) results revealed association of cis-eSNPs in this study with T2D 
and related phenotypes. Although these SNP-disease association results are primarily from 
cohorts of individuals not of African descent, integration of eQTL data from our African 
American participants suggests molecular mechanisms that are putatively regulated by these 
SNPs and sequentially modulating disease susceptibility.
Cis-eSNPs for many adipose and muscle transcripts showed association with T2D and BMI 
in MEDIA (Ng et al., 2014) and AAAGC (Monda et al., 2013) African Americans, 
supporting roles for these transcripts in T2D. Genes modulated by disease-associated cis-
eSNPs (e.g., CD36, CAMK2A, IRS2, POMC, TLR4, XBP1) are involved in the 
pathophysiology of T2D, obesity and related traits; whereas the roles of other cis-eGenes 
(e.g. ADAL, ATP5SL, MCCC1) are unknown. Interestingly, among the target cis-eGenes for 
these GWAS-identified SNPs, mRNA expression of 55 genes in adipose, and 20 genes in 
muscle was significantly associated with glucose homeostasis or obesity phenotypes in 
AAGMEx African Americans. This observation suggests a putative role for these GWAS-
identified SNPs and respective cis-eGenes in the pathophysiology of T2D and related 
metabolic diseases. Association summary statistics were available from the MEDIA and 
AAAGC cohorts for directly genotyped SNPs and HapMap reference panel imputed SNPs. 
Association results for a subset of cis-eSNPs or their proxies (those that were not among the 
HapMap SNPs) were not available from these GWAS. Thus, the role of cis-eSNPs of several 
transcripts identified in this study cannot be evaluated in the MEDIA and AAAGC cohorts.
Target cis-eGenes of T2D-associated SNPs from MEDIA African Americans overlapped 
with target cis-eGenes of glucose homeostasis trait-associated SNPs from MAGIC 
Caucasians. Cis-eSNPs for 18 genes (ACAD10, CUL3, G3BP2, GIN1, HLA-DPA1, HLA-
DPB1, HSPA1B, KCTD10, NOTCH4, PFDN1, PPM1M, RNF41, SNX17, ST7L, 
STARD10, TIPARP, TMEM116, and WDR6) were associated with T2D in MEDIA African 
Americans and were also associated with glucose homeostasis phenotypes (e.g., fasting 
glucose, 2h-OGTT glucose and fasting insulin) in Caucasians from MAGIC. Similarly, 
target cis-eGenes of BMI-associated SNPs from AAAGC African Americans overlapped 
with target cis-eGenes of glucose homeostasis trait-associated SNPs from MAGIC 
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Caucasians. Cis-eSNPs for 12 genes (APIP, ASAP3, BCS1L, GIN1, HSPA1B, PPP1CB, 
RABEP1, RPP40, SNX17, TMEM60, TOM1, and UHRF1BP1) were associated with BMI 
in AAAGC African Americans and were also associated with glucose homeostasis 
phenotypes in MAGIC Caucasians. Thus, regulatory SNP-mediated modulation of the 
transcript expression of some target genes may modulate susceptibility to T2D and related 
gluco-metabolic phenotypes in individuals with either African or European ancestry.
In conclusion, this study identified genetic loci influencing the expression of several genes in 
adipose and muscle of African Americans. Additionally, this study provides data on 
molecular mechanisms putatively regulated by eSNPs and sequentially modulating 
susceptibility for T2D and related metabolic phenotypes in African Americans.
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
 Acknowledgments
We thank the dedicated staff of the Clinical Research Unit at WFSM and Kurt A. Langberg (WFSM-
Endocrinology) for support of the clinical studies and assistance with data management. We thank Mrs. Joyce Byers 
for support in participant recruitment. We thank staff in the genomics core laboratory at Center for Genomics and 
Personalized Medicine Research, WFSM, especially Dr. Siqun Zheng, Shelly Smith, Tracey Young and Dr. Ge Li 
for their extensive support in genotyping, and gene expression analysis using the Illumina microarray platform. We 
acknowledge the support of the Center for Public Health Genomics, WFSM for computational resources. SKD and 
CDL are the guarantors of this work, and as such, had full access to all study data and take responsibility for 
integrity of the data and accuracy of data analysis.
Grants: This work was supported by National Institutes of Health Grant R01 DK090111 (SKD).
REFERENCES
Bergman RN, Stefanovski D, Kim SP. Systems analysis and the prediction and prevention of Type 2 
diabetes mellitus. Curr Opin Biotechnol. 2014; 28:165–170. Epub@2014 Jun 27.:165-170. 
[PubMed: 24976265] 
Cifaldi L, Romania P, Lorenzi S, Locatelli F, Fruci D. Role of endoplasmic reticulum aminopeptidases 
in health and disease: from infection to cancer. Int J Mol Sci. 2012; 13:8338–8352. [PubMed: 
22942706] 
Cowie CC, Harris MI, Silverman RE, Johnson EW, Rust KF. Effect of multiple risk factors on 
differences between blacks and whites in the prevalence of non-insulin-dependent diabetes mellitus 
in the United States. Am J Epidemiol. 1993; 137:719–732. [PubMed: 8484363] 
Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE. 
Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–
2006. Diabetes Care. 2010; 33:562–568. [PubMed: 20067953] 
Das SK, Sharma NK. Expression quantitative trait analyses to identify causal genetic variants for type 
2 diabetes susceptibility. World J Diabetes. 2014; 5:97–114. [PubMed: 24748924] 
Dayem Ullah AZ, Lemoine NR, Chelala C. SNPnexus: a web server for functional annotation of novel 
and publicly known genetic variants (2012 update). Nucleic Acids Res. 2012; 40:W65–W70. 
[PubMed: 22544707] 
Groop L, Pociot F. Genetics of diabetes--are we missing the genes or the disease? Mol Cell 
Endocrinol. 2014; 382:726–739. [PubMed: 23587769] 
Grundberg E, Small KS, Hedman AK, Nica AC, Buil A, Keildson S, Bell JT, Yang TP, Meduri E, 
Barrett A, Nisbett J, Sekowska M, Wilk A, Shin SY, Glass D, Travers M, Min JL, Ring S, Ho K, 
Thorleifsson G, Kong A, Thorsteindottir U, Ainali C, Dimas AS, Hassanali N, Ingle C, Knowles D, 
Sajuthi et al. Page 11
Hum Genet. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Krestyaninova M, Lowe CE, Di MP, Montgomery SB, Parts L, Potter S, Surdulescu G, Tsaprouni L, 
Tsoka S, Bataille V, Durbin R, Nestle FO, O'Rahilly S, Soranzo N, Lindgren CM, Zondervan KT, 
Ahmadi KR, Schadt EE, Stefansson K, Smith GD, McCarthy MI, Deloukas P, Dermitzakis ET, 
Spector TD. Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet. 
2012; 44:1084–1089. [PubMed: 22941192] 
GTEx consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: 
multitissue gene regulation in humans. Science. 2015; 348:648–660. [PubMed: 25954001] 
Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential 
etiologic and functional implications of genome-wide association loci for human diseases and 
traits. Proc Natl Acad Sci U S A. 2009; 106:9362–9367. [PubMed: 19474294] 
Huang, dW; Sherman, BT.; Lempicki, RA. Systematic and integrative analysis of large gene lists using 
DAVID bioinformatics resources. Nat Protoc. 2009; 4:44–57. [PubMed: 19131956] 
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, 
normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 
2003; 4:249–264. [PubMed: 12925520] 
Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical 
Bayes methods. Biostatistics. 2007; 8:118–127. [PubMed: 16632515] 
Keildson S, Fadista J, Ladenvall C, Hedman AK, Elgzyri T, Small KS, Grundberg E, Nica AC, Glass 
D, Richards JB, Barrett A, Nisbet J, Zheng HF, Ronn T, Strom K, Eriksson KF, Prokopenko I, 
Spector TD, Dermitzakis ET, Deloukas P, McCarthy MI, Rung J, Groop L, Franks PW, Lindgren 
CM, Hansson O. Expression of phosphofructokinase in skeletal muscle is influenced by genetic 
variation and associated with insulin sensitivity. Diabetes. 2014; 63:1154–1165. [PubMed: 
24306210] 
Kontro H, Hulmi JJ, Rahkila P, Kainulainen H. Cellular and tissue expression of DAPIT, a 
phylogenetically conserved peptide. Eur J Histochem. 2012; 56:e18. [PubMed: 22688299] 
Mahajan A, Go MJ, Zhang W, Below JE, Gaulton KJ, Ferreira T, Horikoshi M, Johnson AD, Ng MC, 
Prokopenko I, Saleheen D, Wang X, Zeggini E, Abecasis GR, Adair LS, Almgren P, Atalay M, 
Aung T, Baldassarre D, Balkau B, Bao Y, Barnett AH, Barroso I, Basit A, Been LF, Beilby J, Bell 
GI, Benediktsson R, Bergman RN, Boehm BO, Boerwinkle E, Bonnycastle LL, Burtt N, Cai Q, 
Campbell H, Carey J, Cauchi S, Caulfield M, Chan JC, Chang LC, Chang TJ, Chang YC, 
Charpentier G, Chen CH, Chen H, Chen YT, Chia KS, Chidambaram M, Chines PS, Cho NH, Cho 
YM, Chuang LM, Collins FS, Cornelis MC, Couper DJ, Crenshaw AT, van Dam RM, Danesh J, 
Das D, de FU, Dedoussis G, Deloukas P, Dimas AS, Dina C, Doney AS, Donnelly PJ, Dorkhan M, 
van DC, Dupuis J, Edkins S, Elliott P, Emilsson V, Erbel R, Eriksson JG, Escobedo J, Esko T, Eury 
E, Florez JC, Fontanillas P, Forouhi NG, Forsen T, Fox C, Fraser RM, Frayling TM, Froguel P, 
Frossard P, Gao Y, Gertow K, Gieger C, Gigante B, Grallert H, Grant GB, Grrop LC, Groves CJ, 
Grundberg E, Guiducci C, Hamsten A, Han BG, Hara K, Hassanali N, Hattersley AT, Hayward C, 
Hedman AK, Herder C, Hofman A, Holmen OL, Hovingh K, Hreidarsson AB, Hu C, Hu FB, Hui 
J, Humphries SE, Hunt SE, Hunter DJ, Hveem K, Hydrie ZI, Ikegami H, Illig T, Ingelsson E, 
Islam M, Isomaa B, Jackson AU, Jafar T, James A, Jia W, Jockel KH, Jonsson A, Jowett JB, 
Kadowaki T, Kang HM, Kanoni S, Kao WH, Kathiresan S, Kato N, Katulanda P, Keinanen-
Kiukaanniemi KM, Kelly AM, Khan H, Khaw KT, Khor CC, Kim HL, Kim S, Kim YJ, Kinnunen 
L, Klopp N, Kong A, Korpi-Hyovalti E, Kowlessur S, Kraft P, Kravic J, Kristensen MM, Krithika 
S, Kumar A, Kumate J, Kuusisto J, Kwak SH, Laakso M, Lagou V, Lakka TA, Langenberg C, 
Langford C, Lawrence R, Leander K, Lee JM, Lee NR, Li M, Li X, Li Y, Liang J, Liju S, Lim WY, 
Lind L, Lindgren CM, Lindholm E, Liu CT, Liu JJ, Lobbens S, Long J, Loos RJ, Lu W, Luan J, 
Lyssenko V, Ma RC, Maeda S, Magi R, Mannisto S, Matthews DR, Meigs JB, Melander O, 
Metspalu A, Meyer J, Mirza G, Mihailov E, Moebus S, Mohan V, Mohlke KL, Morris AD, 
Muhleisen TW, Muller-Nurasyid M, Musk B, Nakamura J, Nakashima E, Navarro P, Ng PK, Nica 
AC, Nilsson PM, Njolstad I, Nothen MM, Ohnaka K, Ong TH, Owen KR, Palmer CN, Pankow JS, 
Park KS, Parkin M, Pechlivanis S, Pedersen NL, Peltonen L, Perry JR, Peters A, Pinidiyapathirage 
JM, Platou CG, Potter S, Price JF, Qi L, Radha V, Rallidis L, Rasheed A, Rathman W, Rauramaa 
R, Raychaudhuri S, Rayner NW, Rees SD, Rehnberg E, Ripatti S, Robertson N, Roden M, Rossin 
EJ, Rudan I, Rybin D, Saaristo TE, Salomaa V, Saltevo J, Samuel M, Sanghera DK, Saramies J, 
Scott J, Scott LJ, Scott RA, Segre AV, Sehmi J, Sennblad B, Shah N, Shah S, Shera AS. Genome-
Sajuthi et al. Page 12
Hum Genet. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes 
susceptibility. Nat Genet. 2014; 46:234–244. [PubMed: 24509480] 
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: 
comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22:1462–1470. [PubMed: 
10480510] 
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model 
assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin 
concentrations in man. Diabetologia. 1985; 28:412–419. [PubMed: 3899825] 
Mohlke KL, Boehnke M. Recent advances in understanding the genetic architecture of type 2 diabetes. 
Hum Mol Genetddv. 2015; 264
Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, Lange LA, Ng MC, Adeyemo AA, Allison 
MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, Liu Y, Liu Y, Lu Y, Nalls MA, Sun 
YV, Wojczynski MK, Yanek LR, Aldrich MC, Ademola A, Amos CI, Bandera EV, Bock CH, 
Britton A, Broeckel U, Cai Q, Caporaso NE, Carlson CS, Carpten J, Casey G, Chen WM, Chen F, 
Chen YD, Chiang CW, Coetzee GA, Demerath E, Deming-Halverson SL, Driver RW, Dubbert P, 
Feitosa MF, Feng Y, Freedman BI, Gillanders EM, Gottesman O, Guo X, Haritunians T, Harris T, 
Harris CC, Hennis AJ, Hernandez DG, McNeill LH, Howard TD, Howard BV, Howard VJ, 
Johnson KC, Kang SJ, Keating BJ, Kolb S, Kuller LH, Kutlar A, Langefeld CD, Lettre G, Lohman 
K, Lotay V, Lyon H, Manson JE, Maixner W, Meng YA, Monroe KR, Morhason-Bello I, Murphy 
AB, Mychaleckyj JC, Nadukuru R, Nathanson KL, Nayak U, N'diaye A, Nemesure B, Wu SY, 
Leske MC, Neslund-Dudas C, Neuhouser M, Nyante S, Ochs-Balcom H, Ogunniyi A, Ogundiran 
TO, Ojengbede O, Olopade OI, Palmer JR, Ruiz-Narvaez EA, Palmer ND, Press MF, Rampersaud 
E, Rasmussen-Torvik LJ, Rodriguez-Gil JL, Salako B, Schadt EE, Schwartz AG, Shriner DA, 
Siscovick D, Smith SB, Wassertheil-Smoller S, Speliotes EK, Spitz MR, Sucheston L, Taylor H, 
Tayo BO, Tucker MA, Van Den Berg DJ, Edwards DR, Wang Z, Wiencke JK, Winkler TW, Witte 
JS, Wrensch M, Wu X, Yang JJ, Levin AM, Young TR, Zakai NA, Cushman M, Zanetti KA, Zhao 
JH, Zhao W, Zheng Y, Zhou J, Ziegler RG, Zmuda JM, Fernandes JK, Gilkeson GS, Kamen DL, 
Hunt KJ, Spruill IJ, Ambrosone CB, Ambs S, Arnett DK, Atwood L, Becker DM, Berndt SI, 
Bernstein L, Blot WJ, Borecki IB, Bottinger EP, Bowden DW, Burke G, Chanock SJ, Cooper RS, 
Ding J, Duggan D, Evans MK, Fox C, Garvey WT, Bradfield JP, Hakonarson H, Grant SF, Hsing 
A, Chu L, Hu JJ, Huo D, Ingles SA, John EM, Jordan JM, Kabagambe EK, Kardia SL, Kittles RA, 
Goodman PJ, Klein EA, Kolonel LN, Le ML, Liu S, McKnight B, Millikan RC, Mosley TH, 
Padhukasahasram B, Williams LK, Patel SR, Peters U, Pettaway CA, Peyser PA, Psaty BM, 
Redline S, Rotimi CN, Rybicki BA, Sale MM, Schreiner PJ, Signorello LB, Singleton AB, 
Stanford JL, Strom SS, Thun MJ, Vitolins M, Zheng W, Moore JH, Williams SM, Ketkar S, Zhu 
X, Zonderman AB, Kooperberg C, Papanicolaou GJ, Henderson BE, Reiner AP, Hirschhorn JN, 
Loos RJ, North KE, Haiman CA. A meta-analysis identifies new loci associated with body mass 
index in individuals of African ancestry. Nat Genet. 2013; 45:690–696. [PubMed: 23583978] 
Ng MC, Shriner D, Chen BH, Li J, Chen WM, Guo X, Liu J, Bielinski SJ, Yanek LR, Nalls MA, 
Comeau ME, Rasmussen-Torvik LJ, Jensen RA, Evans DS, Sun YV, An P, Patel SR, Lu Y, Long J, 
Armstrong LL, Wagenknecht L, Yang L, Snively BM, Palmer ND, Mudgal P, Langefeld CD, 
Keene KL, Freedman BI, Mychaleckyj JC, Nayak U, Raffel LJ, Goodarzi MO, Chen YD, Taylor 
HA Jr, Correa A, Sims M, Couper D, Pankow JS, Boerwinkle E, Adeyemo A, Doumatey A, Chen 
G, Mathias RA, Vaidya D, Singleton AB, Zonderman AB, Igo RP Jr, Sedor JR, Kabagambe EK, 
Siscovick DS, McKnight B, Rice K, Liu Y, Hsueh WC, Zhao W, Bielak LF, Kraja A, Province 
MA, Bottinger EP, Gottesman O, Cai Q, Zheng W, Blot WJ, Lowe WL, Pacheco JA, Crawford 
DC, Grundberg E, Rich SS, Hayes MG, Shu XO, Loos RJ, Borecki IB, Peyser PA, Cummings SR, 
Psaty BM, Fornage M, Iyengar SK, Evans MK, Becker DM, Kao WH, Wilson JG, Rotter JI, Sale 
MM, Liu S, Rotimi CN, Bowden DW. Meta-analysis of genome-wide association studies in 
African Americans provides insights into the genetic architecture of type 2 diabetes. PLoS Genet. 
2014; 10:e1004517. [PubMed: 25102180] 
Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ. Trait-associated SNPs are more 
likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 2010; 6:e1000888. 
[PubMed: 20369019] 
Paivarinne H, Kainulainen H. DAPIT, a novel protein down-regulated in insulin-sensitive tissues in 
streptozotocin-induced diabetes. Acta Diabetol. 2001; 38:83–86. [PubMed: 11757806] 
Sajuthi et al. Page 13
Hum Genet. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, Magi R, Strawbridge RJ, Rehnberg 
E, Gustafsson S, Kanoni S, Rasmussen-Torvik LJ, Yengo L, Lecoeur C, Shungin D, Sanna S, 
Sidore C, Johnson PC, Jukema JW, Johnson T, Mahajan A, Verweij N, Thorleifsson G, Hottenga 
JJ, Shah S, Smith AV, Sennblad B, Gieger C, Salo P, Perola M, Timpson NJ, Evans DM, Pourcain 
BS, Wu Y, Andrews JS, Hui J, Bielak LF, Zhao W, Horikoshi M, Navarro P, Isaacs A, O'Connell 
JR, Stirrups K, Vitart V, Hayward C, Esko T, Mihailov E, Fraser RM, Fall T, Voight BF, 
Raychaudhuri S, Chen H, Lindgren CM, Morris AP, Rayner NW, Robertson N, Rybin D, Liu CT, 
Beckmann JS, Willems SM, Chines PS, Jackson AU, Kang HM, Stringham HM, Song K, Tanaka 
T, Peden JF, Goel A, Hicks AA, An P, Muller-Nurasyid M, Franco-Cereceda A, Folkersen L, 
Marullo L, Jansen H, Oldehinkel AJ, Bruinenberg M, Pankow JS, North KE, Forouhi NG, Loos 
RJ, Edkins S, Varga TV, Hallmans G, Oksa H, Antonella M, Nagaraja R, Trompet S, Ford I, 
Bakker SJ, Kong A, Kumari M, Gigante B, Herder C, Munroe PB, Caulfield M, Antti J, Mangino 
M, Small K, Miljkovic I, Liu Y, Atalay M, Kiess W, James AL, Rivadeneira F, Uitterlinden AG, 
Palmer CN, Doney AS, Willemsen G, Smit JH, Campbell S, Polasek O, Bonnycastle LL, Hercberg 
S, Dimitriou M, Bolton JL, Fowkes GR, Kovacs P, Lindstrom J, Zemunik T, Bandinelli S, Wild 
SH, Basart HV, Rathmann W, Grallert H, Maerz W, Kleber ME, Boehm BO, Peters A, Pramstaller 
PP, Province MA, Borecki IB, Hastie ND, Rudan I, Campbell H, Watkins H, Farrall M, Stumvoll 
M, Ferrucci L, Waterworth DM, Bergman RN, Collins FS, Tuomilehto J, Watanabe RM, de Geus 
EJ, Penninx BW, Hofman A, Oostra BA, Psaty BM, Vollenweider P, Wilson JF, Wright AF, 
Hovingh GK, Metspalu A, Uusitupa M, Magnusson PK, Kyvik KO, Kaprio J, Price JF, Dedoussis 
GV, Deloukas P, Meneton P, Lind L, Boehnke M, Shuldiner AR, van Duijn CM, Morris AD, 
Toenjes A, Peyser PA, Beilby JP, Korner A, Kuusisto J, Laakso M, Bornstein SR, Schwarz PE, 
Lakka TA, Rauramaa R, Adair LS, Smith GD, Spector TD, Illig T, de FU, Hamsten A, Gudnason 
V, Kivimaki M, Hingorani A, Keinanen-Kiukaanniemi SM, Saaristo TE, Boomsma DI, Stefansson 
K, van der Harst P, Dupuis J, Pedersen NL, Sattar N, Harris TB, Cucca F, Ripatti S, Salomaa V, 
Mohlke KL, Balkau B, Froguel P, Pouta A, Jarvelin MR, Wareham NJ, Bouatia-Naji N, McCarthy 
MI, Franks PW, Meigs JB, Teslovich TM, Florez JC, Langenberg C, Ingelsson E, Prokopenko I, 
Barroso I. Large-scale association analyses identify new loci influencing glycemic traits and 
provide insight into the underlying biological pathways. Nat Genet. 2012; 44:991–1005. [PubMed: 
22885924] 
Shabalin AA. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics. 
2012; 28:1353–1358. [PubMed: 22492648] 
Sharma NK, Sajuthi SP, Chou JW, Calles-Escandon J, Demons J, Rogers S, Ma L, Palmer ND, 
McWilliams R, Beal J, Comeau M, Cherry K, Hawkins GA, Menon L, Kouba E, Davis D, Burris 
M, Byerly SJ, Easter L, Bowden DW, Freedman BI, Langefeld CD, Das SK. Tissue-specific and 
Genetic Regulation of Insulin Sensitivity-Associated Transcripts in African Americans. J Clin 
Endocrinol Metab. 2016; 101:1455–1468. [PubMed: 26789776] 
Storey JD, Madeoy J, Strout JL, Wurfel M, Ronald J, Akey JM. Gene-expression variation within and 
among human populations. Am J Hum Genet. 2007; 80:502–509. [PubMed: 17273971] 
Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R, Hunt S, Kahl B, Antonarakis 
SE, Tavare S, Deloukas P, Dermitzakis ET. Genome-wide associations of gene expression variation 
in humans. PLoS Genet. 2005; 1:e78. [PubMed: 16362079] 
Stranger BE, Montgomery SB, Dimas AS, Parts L, Stegle O, Ingle CE, Sekowska M, Smith GD, Evans 
D, Gutierrez-Arcelus M, Price A, Raj T, Nisbett J, Nica AC, Beazley C, Durbin R, Deloukas P, 
Dermitzakis ET. Patterns of cis regulatory variation in diverse human populations. PLoS Genet. 
2012; 8:e1002639. [PubMed: 22532805] 
Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, Ingle CE, Dunning M, Flicek P, 
Koller D, Montgomery S, Tavare S, Deloukas P, Dermitzakis ET. Population genomics of human 
gene expression. Nat Genet. 2007; 39:1217–1224. [PubMed: 17873874] 
Veyrieras JB, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, Stephens M, Pritchard JK. High-
resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 
2008; 4:e1000214. [PubMed: 18846210] 
Zhang W, Duan S, Kistner EO, Bleibel WK, Huang RS, Clark TA, Chen TX, Schweitzer AC, Blume 
JE, Cox NJ, Dolan ME. Evaluation of genetic variation contributing to differences in gene 
expression between populations. Am J Hum Genet. 2008; 82:631–640. [PubMed: 18313023] 
Sajuthi et al. Page 14
Hum Genet. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Expression quantitative trait locus (eQTL) analysis identified regulatory 
polymorphisms for adipose and muscle tissue transcripts in African Americans
Opposing Manhattan plot showing chromosomal distribution of −log10(p-values) for 
association of all cis-SNPs (±500 kb of the transcript start and end) tested for transcripts (all 
probes representing refSeq genes) expressed in adipose and muscle. Significance threshold 
(Q-value <0.01) is marked by fluorescent yellow color lines. (A). A Venn diagram (B) shows 
common and tissue specific cis- and trans-eGenes (FDR<0.01 and selected clean probes 
representing known genes) in adipose and muscle. Top cis-eSNPs for 317 transcripts showed 
the same direction of effect in both tissues (C)
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Figure 2. Physical location of cis-eSNPs with respect to transcription start sites of each gene
Distance distribution of each transcript’s most strongly associated cis-eSNPs (FDR<0.01) to 
its TSS in adipose (A) and muscle (B). Each bar represents the count of top cis-eSNPs in 
10kb bins. Plots C and D show distribution of significance level (−log10 p-values) of all 
genotyped cis-eSNPs (FDR<0.01) relative to TSS in adipose and muscle.
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Figure 3. Genomic distribution and functional annotation of cis-eSNPs
Bar graph shows functional annotation of each adipose and muscle tissue transcript’s most 
strongly associated cis-eSNPs (FDR<0.01) in the genome.
Sajuthi et al. Page 17
Hum Genet. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Sajuthi et al. Page 18
Ta
bl
e 
1
To
p 
20
 c
is-
eQ
TL
s c
om
mo
n i
n a
dip
os
e a
nd
 m
us
cle
 tis
su
e o
f A
fri
ca
n A
me
ric
an
s
ci
s-
eS
N
P
C
hr
A
1
M
A
F
A
di
po
se
M
us
cl
e
Pr
o
be
 ID
En
tr
ez
G
en
e I
D
Sy
m
bo
l
β
P-
v
a
lu
e
Q-
v
a
lu
e
β
P-
v
a
lu
e
Q-
v
a
lu
e
rs
71
43
43
2
14
C
0.
39
1
0.
96
1.
97
E-
12
5
7.
97
E-
11
9
1.
10
1.
58
E-
12
5
2.
23
E-
11
9
IL
M
N
_1
79
81
77
91
61
2
CH
UR
C1
rs
11
19
16
42
10
G
0.
09
1
1.
13
1.
59
E-
11
7
1.
61
E-
11
1
1.
18
1.
36
E-
14
6
3.
36
E-
14
0
IL
M
N
_1
77
33
13
84
83
3
U
SM
G5
rs
74
34
55
71
5
G
0.
44
0
1.
03
4.
60
E-
11
3
3.
49
E-
10
7
0.
45
2.
52
E-
11
1
1.
18
E-
10
5
IL
M
N
_1
74
31
45
64
16
7
ER
A
P2
rs
10
55
34
0
10
A
0.
25
1
−
0.
41
2.
91
E-
83
8.
03
E-
78
−
0.
32
1.
58
E-
64
1.
44
E-
59
IL
M
N
_1
79
53
36
93
17
PT
ER
rs
84
13
9
G
0.
36
5
−
0.
40
3.
42
E-
83
9.
02
E-
78
−
0.
28
2.
75
E-
82
4.
74
E-
77
IL
M
N
_1
81
13
01
56
62
3
IN
PP
5E
rs
20
01
98
99
9
18
G
0.
19
1
−
0.
60
3.
01
E-
72
5.
63
E-
67
−
0.
40
4.
18
E-
61
3.
24
E-
56
IL
M
N
_1
77
65
15
65
25
8
M
PP
E1
rs
21
37
47
1
8
G
0.
39
6
−
0.
40
3.
45
E-
72
6.
34
E-
67
−
0.
23
1.
79
E-
54
9.
46
E-
50
IL
M
N
_1
72
00
59
79
61
8
H
M
BO
X
1
rs
59
34
74
16
9
T
0.
15
3
−
0.
54
2.
44
E-
71
4.
28
E-
66
−
0.
21
1.
55
E-
53
7.
87
E-
49
IL
M
N
_1
74
49
80
84
18
6
ZC
CH
C7
rs
22
32
74
5
2
T
0.
45
7
−
0.
34
8.
32
E-
68
1.
23
E-
62
−
0.
29
2.
54
E-
66
2.
63
E-
61
IL
M
N
_1
65
53
40
51
25
5
RN
F1
81
rs
68
73
91
2
5
A
0.
27
1
0.
39
3.
47
E-
67
5.
02
E-
62
0.
49
5.
95
E-
81
9.
44
E-
76
IL
M
N
_2
10
32
95
10
41
2
TI
N
P1
rs
70
21
97
7
9
A
0.
32
7
0.
43
3.
66
E-
67
5.
23
E-
62
0.
37
2.
42
E-
49
9.
58
E-
45
IL
M
N
_1
80
86
61
40
15
05
TO
M
M
5
rs
28
40
56
87
2
T
0.
37
5
0.
40
1.
11
E-
66
1.
50
E-
61
0.
34
1.
73
E-
54
9.
22
E-
50
IL
M
N
_1
77
00
20
53
93
8
PP
IL
3
rs
66
63
12
T
0.
16
5
0.
55
1.
75
E-
65
2.
13
E-
60
0.
15
1.
18
E-
39
2.
66
E-
35
IL
M
N
_1
71
90
64
83
89
2
K
CT
D1
0
rs
68
73
91
2
5
A
0.
27
1
0.
42
2.
41
E-
57
1.
80
E-
52
0.
50
2.
02
E-
81
3.
26
E-
76
IL
M
N
_1
69
42
59
10
41
2
N
SA
2
rs
37
96
68
3
4
T
0.
36
6
−
0.
58
3.
31
E-
53
2.
09
E-
48
−
0.
40
2.
36
E-
47
8.
22
E-
43
IL
M
N
_1
65
65
60
25
84
9
PA
RM
1
rs
73
99
23
09
17
G
0.
06
4
−
0.
47
9.
31
E-
50
5.
00
E-
45
−
0.
61
8.
54
E-
61
6.
46
E-
56
IL
M
N
_1
68
51
12
51
20
4
TA
CO
1
rs
73
36
62
29
17
C
0.
27
0
0.
38
4.
57
E-
49
2.
36
E-
44
0.
15
7.
24
E-
21
3.
47
E-
17
IL
M
N
_1
72
07
08
14
53
CS
NK
1D
rs
17
85
60
37
14
T
0.
17
8
−
0.
73
1.
37
E-
44
5.
73
E-
40
−
0.
39
1.
11
E-
30
1.
33
E-
26
IL
M
N
_3
24
37
44
55
83
7
EA
PP
rs
32
11
93
8
7
G
0.
10
0
−
0.
86
9.
59
E-
44
3.
78
E-
39
−
0.
98
2.
37
E-
35
4.
01
E-
31
IL
M
N
_1
79
60
94
94
8
CD
36
rs
29
08
70
0
12
C
0.
41
5
0.
40
2.
72
E-
43
1.
04
E-
38
0.
18
1.
73
E-
23
1.
11
E-
19
IL
M
N
_1
78
46
08
99
76
CL
EC
2B
Sh
ow
n
 a
re
 th
e 
ci
s-
eS
N
Ps
 (g
en
oty
pe
d S
NP
 w
ith
in 
±5
00
kb
 of
 th
e 5
' a
nd
 3'
 en
d o
f t
he
 tr
an
scr
ipt
) t
ha
t a
re 
mo
st 
str
on
gly
 as
so
cia
ted
 (Q
-va
lu
e 
< 
0.
01
) a
nd
 in
 th
e s
am
e d
ire
cti
on
 fo
r t
he
 sa
me
 tr
an
scr
ipt
s. 
Ch
r, 
Ch
ro
m
os
om
e;
 A
1,
 M
in
or
 A
lle
le
; M
A
F,
 
M
in
or
 A
lle
le
 F
re
qu
en
cy
; β
,
 
ef
fe
ct
 si
ze
 o
f m
in
or
 a
lle
le
 (A
1);
 P-
va
lu
e,
 si
gn
ifi
ca
nc
e 
in
 a
dd
iti
v
e 
m
o
de
l (
M
atr
ixE
QT
L 
an
aly
sis
); 
Q-
va
lu
e,
 fa
lse
 d
isc
ov
er
y 
ra
te
. R
es
ul
ts 
fo
r 
al
l 3
17
 c
is-
eG
en
es
 a
ss
oc
ia
te
d 
w
ith
 sa
m
e 
ci
s-
eS
N
Ps
 a
nd
 sh
ow
in
g 
th
e 
sa
m
e 
al
le
le
 d
ire
ct
io
n 
of
 e
ffe
ct
 in
 b
ot
h 
tis
su
es
 a
re
 p
ro
v
id
ed
 in
 S
up
pl
em
en
ta
ry
 T
ab
le
 4
.
Hum Genet. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Sajuthi et al. Page 19
Ta
bl
e 
2
ci
s-
eS
N
Ps
 fo
r a
di
po
se
 a
nd
 m
us
cl
e 
tis
su
e 
tra
ns
cr
ip
ts 
as
so
ci
at
ed
 w
ith
 T
2D
 a
nd
 B
M
I i
n 
G
W
A
S 
m
et
a-
an
al
ys
is 
in
 A
fri
ca
n 
A
m
er
ic
an
 S
ub
jec
ts
A
) e
SN
Ps
 (F
DR
 1%
) f
ro
m
 th
e 
A
AG
M
Ex
 co
ho
rt
 a
re
 a
ss
o
ci
at
ed
 w
ith
 T
2D
 (p
≤ 0
.00
01
) in
 th
e "
M
eta
-an
aly
sis
 of
 T
yp
e
2 
D
ia
be
te
s i
n 
A
fr
ic
an
 A
m
er
ic
an
s”
 C
on
so
rt
iu
m
 co
ho
rt
s.
SN
P
SN
P
C
hr
SN
P
Po
s
A
1
M
A
F
Ill
um
in
ap
ro
be
_I
D
Ti
ss
ue
β
P
Va
lu
ea
Sy
m
bo
l
En
tr
ez
G
en
e
_
ID
A
lle
le
1
Fr
eq
1
O
R
(95
%
CI
)
P
Va
lu
eb
N
rs
15
94
2
20
20
25
62
1
C
0.
44
3
IL
M
N
_1
77
00
20
A
d
−
0.
16
6
5.
90
E-
09
PP
IL
3
53
93
8
A
0.
52
7
0.
91
2
(0.
87
3–
0.9
53
)
4.
17
E-
05
23
73
7
IL
M
N
_1
78
98
30
A
d
0.
11
9
5.
07
E-
07
CF
LA
R
88
37
IL
M
N
_1
77
00
20
M
u
−
0.
11
4
1.
01
E-
05
PP
IL
3
53
93
8
IL
M
N
_1
78
98
30
M
u
0.
08
6
2.
45
E-
05
CF
LA
R
88
37
rs
29
30
53
2
15
44
13
38
90
C
0.
19
1
IL
M
N
_1
72
50
43
A
d
−
0.
06
8
1.
08
E-
05
A
DA
L
16
18
23
T
0.
81
3
1.
13
7
(1.
06
9–
1.2
10
)
4.
89
E-
05
21
26
1
IL
M
N
_1
72
50
43
M
u
−
0.
06
5
1.
32
E-
07
rs
72
59
20
8
19
41
89
46
78
A
0.
09
4
IL
M
N
_1
80
90
27
A
d
0.
16
3
5.
64
E-
09
AT
P5
SL
55
10
1
A
0.
09
6
1.
18
4
(1.
09
8–
1.2
77
)
1.
20
E-
05
22
75
5
IL
M
N
_1
80
90
27
M
u
0.
15
6
1.
18
E-
06
B)
 eS
NP
s (
FD
R 
1%
) f
ro
m
 th
e 
A
AG
M
Ex
 co
ho
rt
 a
re
 a
ss
o
ci
at
ed
 w
ith
 B
M
I (
p≤
 0.
00
01
) in
 th
e "
Af
ric
an
 A
nc
est
ry
A
nt
hr
o
po
m
et
ry
 G
en
et
ic
 C
on
so
rt
iu
m
" 
co
ho
rt
s
SN
P
SN
P
C
hr
SN
P
Po
s
A
1
M
A
F
Ill
um
in
a
pr
o
be
_I
D
Ti
ss
ue
β
P
Va
lu
ea
Sy
m
bo
l
En
tr
ez
G
en
e
_
ID
A
lle
le
1
Fr
eq
1
Ef
fe
ct
(S
E)
P
Va
lu
eb
N
rs
40
74
11
0
3
18
27
28
66
9
C
0.
14
0
IL
M
N
_1
76
01
74
M
u
0.
10
9
6.
65
E-
08
M
CC
C1
56
92
2
A
0.
83
0
−
0.
05
1
(0.
01
1)
6.
11
E-
06
37
03
3
rs
60
05
88
1
22
29
18
31
33
A
0.
33
6
IL
M
N
_1
80
94
33
M
u
0.
08
2
2.
60
E-
06
X
BP
1
74
94
A
0.
35
1
−
0.
03
4
(0.
00
8)
3.
62
E-
05
38
49
7
rs
70
18
46
9
9
11
41
95
27
4
C
0.
14
0
IL
M
N
_1
70
45
31
A
d
0.
42
9
2.
81
E-
18
PT
GR
1
22
94
9
T
0.
87
0
−
0.
05
8
(0.
01
3)
1.
86
E-
05
29
37
0
IL
M
N
_2
22
55
37
A
d
0.
46
3
4.
50
E-
22
PT
GR
1
IL
M
N
_1
70
45
31
M
u
0.
17
3
9.
68
E-
17
PT
GR
1
IL
M
N
_2
22
55
37
M
u
0.
20
5
7.
85
E-
20
PT
GR
1
Hum Genet. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Sajuthi et al. Page 20
B)
 eS
NP
s (
FD
R 
1%
) f
ro
m
 th
e 
A
AG
M
Ex
 co
ho
rt
 a
re
 a
ss
o
ci
at
ed
 w
ith
 B
M
I (
p≤
 0.
00
01
) in
 th
e "
Af
ric
an
 A
nc
est
ry
A
nt
hr
o
po
m
et
ry
 G
en
et
ic
 C
on
so
rt
iu
m
" 
co
ho
rt
s
SN
P
SN
P
C
hr
SN
P
Po
s
A
1
M
A
F
Ill
um
in
a
pr
o
be
_I
D
Ti
ss
ue
β
P
Va
lu
ea
Sy
m
bo
l
En
tr
ez
G
en
e
_
ID
A
lle
le
1
Fr
eq
1
Ef
fe
ct
(S
E)
P
Va
lu
eb
N
rs
79
49
56
7
11
85
25
10
05
G
0.
34
6
IL
M
N
_1
78
48
47
A
d
−
0.
07
1
2.
17
E-
07
CR
EB
ZF
58
48
7
A
0.
63
3
0.
03
6
(0.
00
8)
7.
10
E-
06
39
13
0
IL
M
N
_2
33
66
09
M
u
−
0.
22
5
4.
21
E-
10
SY
TL
2
54
84
3
IL
M
N
_2
21
78
09
0.
21
1
6.
42
E-
24
TM
EM
12
6A
84
23
3
In
 eQ
TL
 an
aly
sis
 
A
1,
 M
in
or
 A
lle
le
; M
A
F,
 
M
in
or
 A
lle
le
 F
re
qu
en
cy
; β
,
 
ef
fe
ct
 si
ze
 o
f m
in
or
 a
lle
le
 (A
1);
P-
va
lu
ea
,
 
sig
ni
fic
an
ce
 in
 a
dd
iti
v
e 
m
o
de
l; 
Q-
va
lu
e,
 fa
lse
 d
isc
ov
er
y 
ra
te
. I
n 
T2
D
 an
d 
BM
I G
W
A
S 
m
eta
-a
na
ly
sis
 
A
lle
le
1,
 e
ffe
ct
 a
lle
le
; F
re
q1
, f
re
qu
en
cy
 o
f e
ffe
ct
 a
lle
le
;
P-
va
lu
eb
,
 
G
W
A
S 
M
et
a-
an
al
ys
is 
p-
va
lu
es
. A
d,
 su
bc
ut
an
eo
us
 a
di
po
se
 ti
ss
ue
; M
u,
 sk
el
et
al
 m
us
cl
e 
tis
su
e.
 O
th
er
 T
2D
 o
r B
M
I a
ss
oc
ia
te
d 
(p<
0.0
1) 
eS
NP
s a
re 
sh
ow
n
 in
 su
pp
le
m
en
ta
ry
 ta
bl
e 
9 
an
d 
10
.
Hum Genet. Author manuscript; available in PMC 2017 August 01.
